Life Sciences Tools and Services
Company Overview of XenTech SAS
XenTech SAS, a contract research organization, offers tumorgraft-based services in preclinical oncology. It engages in preclinical pharmacology studies and evaluation of novel anti-tumor agents. The company also provides efficacy studies on human tumor xenografts. In addition, it offers pre-clinical consulting; tumor collection; drug efficacy assays, such as in vivo efficacy assays and in vitro assays; molecular database; and other services, including real-time in vivo fluorescence and bioluminescence imaging, and custom-made tumor models. XenTech SAS was incorporated in 2006 and is based in Evry, France.
4, rue Pierre Fontaine
Founded in 2006
33 1 60 87 89 80
33 1 60 87 89 62
Key Executives for XenTech SAS
Similar Private Companies By Industry
|Advanced BioDesign SAS||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact XenTech SAS, please visit www.xentech.eu. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.